Home » Stocks » Avid Bioservices

Avid Bioservices, Inc. (CDMO)

Stock Price: $7.73 USD 0.06 (0.78%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 436.83M
Revenue (ttm) 59.70M
Net Income (ttm) -10.47M
Shares Out 56.51M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE 714.29
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $7.73
Previous Close $7.67
Change ($) 0.06
Change (%) 0.78%
Day's Open 7.62
Day's Range 7.52 - 8.00
Day's Volume 415,819
52-Week Range 3.02 - 8.38

More Stats

Market Cap 436.83M
Enterprise Value 427.07M
Earnings Date (est) Sep 14, 2020
Ex-Dividend Date n/a
Shares Outstanding 56.51M
Float 39.52M
EPS (basic) -0.27
EPS (diluted) -0.27
FCF / Share 0.04
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 0.46%
Payout Ratio n/a
Shares Short 2.41M
Short Ratio 4.93
Short % of Float 4.54%
Beta 2.25
PE Ratio n/a
Forward PE 714.29
P/FCF Ratio 216.79
PS Ratio 7.32
PB Ratio 10.01
Revenue 59.70M
Operating Income -10.94M
Net Income -10.47M
Free Cash Flow 2.02M
Net Cash 9.76M
Net Cash / Share 0.17
Gross Margin 6.59%
Operating Margin -18.32%
Profit Margin -25.40%
FCF Margin 3.38%
ROA -7.11%
ROE -22.04%
ROIC -17.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$9.67*
(25.10% upside)
Low
9.00
Current: $7.73
High
10.00
Target: 9.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue59.7053.6053.6257.6344.3626.7822.4021.6815.2313.49
Revenue Growth11.38%-0.03%-6.96%29.92%65.63%19.55%3.31%42.34%12.9%-
Gross Profit3.937.22-2.9219.3721.3911.199.299.095.086.20
Operating Income-10.94-5.62-20.641.293.49-50.50-35.71-28.35-42.07-34.69
Net Income-10.47-4.22-21.81-28.16-55.65-50.36-35.36-29.78-42.12-34.15
Shares Outstanding56.3355.9847.0637.1130.9026.0823.0817.2011.948.70
Earnings Per Share-0.27-0.16-0.56-0.88-1.95-2.07-1.54-1.75-3.50-3.92
Operating Cash Flow5.83-11.60-25.99-39.17-39.59-36.02-28.25-20.93-35.88-26.46
Capital Expenditures-3.814.54-0.79-3.63-8.88-9.05-0.76-0.85-1.55-0.91
Free Cash Flow2.02-7.05-26.79-42.80-48.47-45.07-29.01-21.78-37.43-27.37
Cash & Equivalents36.6133.5043.4247.9562.0168.0077.4935.2018.0323.08
Total Debt26.85--------1.32
Net Cash / Debt9.7633.5043.4247.9562.0168.0077.4935.2018.0321.75
Assets10878.4095.7611810997.4690.5545.0628.2634.77
Liabilities65.7225.3340.0264.5358.9738.4322.8521.3018.7819.35
Book Value41.9053.0755.7453.5850.0759.0467.7023.769.4815.42
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avid Bioservices, Inc.
Country United States
Employees 222
CEO Nicholas Green

Stock Information

Ticker Symbol CDMO
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CDMO

Description

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.